Comparative Studies of Noopept and Piracetam in the Treatment of Patients With Mild Cognitive Disorders in Organic Brain Diseases of Vascular and Traumatic Origin

Neurosci Behav Physiol. 2009 Mar;39(3):311-21. doi: 10.1007/s11055-009-9128-4.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Brain Diseases / complications*
  • Brain Diseases / etiology
  • Brain Injuries / complications*
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / etiology*
  • Dipeptides / administration & dosage
  • Dipeptides / therapeutic use*
  • Humans
  • Middle Aged
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / therapeutic use*
  • Nootropic Agents / administration & dosage
  • Nootropic Agents / therapeutic use*
  • Piracetam / administration & dosage
  • Piracetam / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Dipeptides
  • Neuroprotective Agents
  • Nootropic Agents
  • ethyl phenylacetyl-Pro-Gly
  • Piracetam